Biricodar
- "Incel" redirects here. The term is also sometimes used to refer to involuntary celibacy.
| File:Biricodar.svg | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C34H41N3O7 |
| Molar mass | 603.705 g/mol |
|
WikiDoc Resources for Biricodar |
|
Articles |
|---|
|
Most recent articles on Biricodar |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Biricodar at Clinical Trials.gov Clinical Trials on Biricodar at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Biricodar
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Biricodar Discussion groups on Biricodar Directions to Hospitals Treating Biricodar Risk calculators and risk factors for Biricodar
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Biricodar |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Biricodar (INN, codename VX-170, marketed as the dicitrate salt under the trade name Incel) is a pharmaceutical drug released by Vertex Pharmaceuticals in 1999 to help treat ovarian cancer patients.
External links
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Chemotherapeutic agents